NGS Sample Preparation Market Is Set To Reach $5,501.2 Million by 2030, says P&S Intelligence

NEW YORK, May 11, 2022 /PRNewswire/ -- The global NGS sample preparation market was worth around $1,598.8 million in 2021, and it is expected to reach $5,501.2 million by 2030, according to P&S Intlligrowing at a CAGR of 14.7% from 2021 to 2030, says P&S Intelligence. Due to the rise in medical research activities and the presence of prominent technology suppliers, the APAC market is expected to archive the fastest growth in the near future. Next-generation sequencing (NGS) is a high-throughput technology that may be used to learn about any organism at the transcriptomic, genomic, or epigenetic level.

P&S Intelligence Logo

The pandemic has had a positive influence on the market. To study the virus's structure, the genomic sequence of its etiological agent had to be rebuilt right away. Furthermore, the testing procedure for virus-infected persons has become easier owing to NGS, allowing healthcare experts to create tailored medications for their treatment.

Get the sample pages of this report at:

Key Findings of NGS Sample Preparation Market Report

  • Twist Bioscience Corporation and C2I Genomics Inc., a cancer intelligence firm, confirmed a partnership in February 2022 to create whole-genome cancer reference materials.
  • Agilent Technologies Inc. purchased Resolution Bioscience Inc., a company involved in the commercialization and development of NGS solutions, in April 2021, to expand its precision oncology testing services to patients worldwide.
  • The North American NGS sample preparation market accounts for the biggest revenue share, and it is predicted to grow at a fast pace during the forecast period. This is due to the increasing R&D in NGS and its potential applications in clinical practices.
  • The market will also grow due to the significant expansion of the life sciences industry. The demand for NGS samples is driven by the industry's high adoption of improved technologies, growth in developing countries, and increase in scientific and technological skills.
  • In 2021, the DNA sequencing category held the largest market share, and this trend is projected to continue in the future. Because DNA sequencing is more cost-effective and faster than manual sequencing, it is the most-common use of NGS samples.
  • By 2030, the NGS sample preparation market is set to generate $2.2 billion in revenue from academic and research organizations. This is credited to the strong focus on R&D, which is why governments and private firms are increasing their research funding. Moreover, the development of new technologies and growing financial support for the enhancement of NGS products and services are propelling the market.

Browse detailed report on Global Next-Generation Sequencing Sample Preparation Market Size, Share, Competition Analysis, and Growth Prospects

In 2021, the consumables category dominated the market, and it is expected to continue its dominance in the future. The growing demand for testing and associated equipment and components, as well as the pertinent research in DNA, RNA, and whole-genome sequencing, supports the demand for consumables. Low-volume, kits, microplates, reagents, storage plates, and pipettes are some of the important consumables involved in sample preparation.

To gain a competitive advantage, key players in the NGS sample preparation market are forming alliances and acquiring companies. These players are Becton, Dickinson and Company, F. Hoffmann-La Roche Ltd., Agilent Technologies Inc., Oxford Nanopore Technologies plc, New England Biolabs Inc., Integrated DNA Technologies Inc., Illumina Inc., Pacific Biosciences of California Inc., and Beckman Coulter Inc.

NGS Sample Preparation Market Segmentation Analysis

By Product

  • Consumables
    • Library preparation kits
    • Sample purification kits
    • Sample extraction and isolation kits
    • Target enrichment kits
    • Cleanup and selection kits
    • Microbiome DNA enrichment kits
  • Automated Workstations
    • Open systems
    • Closed systems
  • Standalone Automated Instruments
    • Fragment analyzers
    • Nucleic acid extraction/isolation systems
    • DNA selection instruments
    • DNA/RNA shearing instruments
    • Template preparation instruments
    • Ultrasonicators/Sonicators
  • Accessories

By Workflow

  • Library Preparation
  • Target Enrichment
  • Sample Extraction/Isolation
  • Fragmentation
  • Sample Quantification
  • Library Quantification
  • Quality Control (QC)
  • Pooling

By Therapeutic Area

  • Oncology
  • Infectious Diseases
  • Human Genetics/Population Genetics
  • Others

By Application

  • DNA Sequencing
  • Whole Genome Sequencing
  • RNA Sequencing
  • Methylation Sequencing

By End User

  • Hospitals and Clinics
  • Academic and Research Institutions
  • Pharmaceutical and Biotechnology Companies

Regional Analysis

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • France
    • Spain
    • Italy
  • Asia-Pacific
    • China
    • India
    • Japan
    • South Korea
    • Australia
  • Latin America
    • Brazil
    • Mexico
  • Middle East and Africa
    • Saudi Arabia
    • South Africa

Browse More Related Reports

Global Carrier Screening Market Revenue Estimation and Demand Forecast Report

Global Biosimilars Market Revenue Estimation and Demand Forecast Report

Global Molecular Cytogenetics Market Revenue Estimation and Demand Forecast Report

Global Gene Therapy Market Revenue Estimation and Demand Forecast Report

Global Generic Drugs Market Revenue Estimation and Demand Forecast Report

About P&S Intelligence

P&S Intelligence provides market research and consulting services to a vast array of industries across the world. As an enterprising research and consulting company, P&S believes in providing thorough insights on the ever-changing market scenario, to empower companies to make informed decisions and base their business strategies with astuteness. P&S keeps the interest of its clients at heart, which is why the insights we provide are both honest and accurate. Our long list of satisfied clients includes entry-level firms as well as multi-million-dollar businesses and government agencies.

Prajneesh Kumar
P&S Intelligence
Phone: +1-347-960-6455
Follow Us: LinkedIn Twitter


Cision View original content:

SOURCE P&S Intelligence

News, commentary and research reports are from third-party sources unaffiliated with Fidelity. Fidelity does not endorse or adopt their content. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use.